Growth Metrics

Merck (MRK) Operating Income Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -105.29%
Dec 31, 2025 22.40%
Sep 30, 2025 62.74%
Jun 30, 2025 199.84%
Mar 31, 2025 36.41%
Dec 31, 2024 16.12%
Sep 30, 2024 14.94%
Jun 30, 2024 78.11%
Mar 31, 2024 169.44%
Dec 31, 2023 -54.13%
Sep 30, 2023 27.89%
Jun 30, 2023 -47.71%
Mar 31, 2023 31.57%
Dec 31, 2022 25.10%
Sep 30, 2022 35.35%
Jun 30, 2022 19.14%
Mar 31, 2022 13.08%
Dec 31, 2021 14.95%
Sep 30, 2021 40.52%
Jun 30, 2021 7.73%
Mar 31, 2021 35.83%
Dec 31, 2020 -20.08%
Sep 30, 2020 25.79%
Jun 30, 2020 71.04%
Mar 31, 2020 17.51%
Dec 31, 2019 -18.95%
Sep 30, 2019 9.68%
Jun 30, 2019 45.68%
Mar 31, 2019 14.96%
Dec 31, 2018 27.34%
Sep 30, 2018 18.04%
Jun 30, 2018 15.22%
Mar 31, 2018 5.26%
Dec 31, 2017 11.19%
Sep 30, 2017 -10.12%
Jun 30, 2017 13.91%
Mar 31, 2017 7.32%
Dec 31, 2016 -13.22%
Sep 30, 2016 23.56%
Jun 30, 2016 4.51%
Mar 31, 2016 3.52%
Dec 31, 2015 10.01%
Sep 30, 2015 18.06%
Jun 30, 2015 2.28%
Mar 31, 2015 -40.07%
Dec 31, 2014 46.18%
Sep 30, 2014 -29.99%
Jun 30, 2014 -33.05%
Mar 31, 2014 -29.22%